FusionPharm, Inc. operates in the organic/locally produced food industry. The Company develops and integrates its PharmPod line of cultivation containers.

According to the law firm press release, the Complaint alleges that Defendants caused the Company to issue materially misleading statements and/or omit material information concerning the Company's business, operations and prospects in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. In particular, the Complaint alleges that Defendants caused the Company to issue materially misleading representations and/or omit material information regarding the Company's purported revenues and sales of its PharmPods during the Class Period.

This case was voluntarily dismissed on June 13, 2017.